Cambridge, Massachusetts Thursday, October 17, 2024, 17:00 Hrs [IST] ...

The work presented will be of interest to cancer biologists and more broadly to those interested in NSCLC translational studies. Non-small cell lung cancer (NSCLC) is the most common subtype of lung ...

In this randomized controlled trial, among adolescent girls and young women, it was found that twice-yearly lenacapavir ...

A copy of the posters and presentation will be available on the company’s website following the conference.

BeiGene has seven presentations at IWWM 2024, and Mehrdad Mobasher, M.D., M.P.H., Chief Medical Officer, Hematology at BeiGene, will give the opening ceremony keynote, “Innovating for Impact: How ...

Subcutaneously administered AK006 showed approximately 77% bioavailability and prolonged receptor occupancy on mast cells –– Subcutaneous AK006 ...

Longhorn Vaccines and Diagnostics, a One Health company developing vaccines and diagnostic tools for global public health and zoonosis concerns, will present new data at IDWeek 2024 focused on ...

Vir Biotechnology, Inc. today announced it will present new data from the Phase 2 SOLSTICE clinical trial evaluating the efficacy and safety profile of tobevibart, an investigational monoclonal ...

Clarity Pharmaceuticals Dr Alan Taylor    Catherine Strong Executive Chairman   Investor/Media Relations ataylor@claritypharm.

It is believed that corticosteroids induce their effects on the cell through a glucocorticoid ... it is inexpensive and has a short serum half-life), (3) administer in the morning to maintain ...